Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

166 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Erythematous capillary-lymphatic malformations mimicking blood vascular anomalies.
Hägerling R, Van Zanten M, Behncke RY, Ulferts S, Hansmeier NR, Märkl B, Witzel C, Ho B, Keeley V, Riches K, Mansour S, Gordon K, Ostergaard P, Mortimer PS. Hägerling R, et al. Among authors: markl b. JCI Insight. 2023 Oct 23;8(20):e172179. doi: 10.1172/jci.insight.172179. JCI Insight. 2023. PMID: 37698920 Free PMC article.
Comparative Study of Virus and Lymphocyte Distribution with clinical Data suggests early high dose Immunosuppression as potential Key Factor for the Therapy of Patients with BoDV-1 Infection.
Vollmuth Y, Jungbäck N, Mögele T, Schmidt-Graf F, Wunderlich S, Schimmel M, Rothe C, Stark L, Schlegel J, Rieder G, Richter T, Schaller T, Tappe D, Märkl B, Matiasek K, Liesche-Starnecker F. Vollmuth Y, et al. Among authors: markl b. Emerg Microbes Infect. 2024 Apr 30:2350168. doi: 10.1080/22221751.2024.2350168. Online ahead of print. Emerg Microbes Infect. 2024. PMID: 38687703 Free article.
Endoscopic Submucosal Dissection for Early Esophageal Adenocarcinoma: Low Rates of Metastases in Mucosal Cancers with Poor Differentiation.
Probst A, Kappler F, Ebigbo A, Albers D, Faiss S, Steinbrück I, Wannhoff A, Allgaier HP, Denzer U, Rempel V, Reinehr R, Dakkak D, Mende M, Pohl J, Schaller T, Märkl B, Muzalyova A, Fleischmann C, Messmann H. Probst A, et al. Among authors: markl b. Gastrointest Endosc. 2024 Mar 11:S0016-5107(24)00166-4. doi: 10.1016/j.gie.2024.03.013. Online ahead of print. Gastrointest Endosc. 2024. PMID: 38479623 Free article.
PITX2 as a Sensitive and Specific Marker of Midgut Neuroendocrine Tumors: Results from a Cohort of 1157 Primary Neuroendocrine Neoplasms.
Grass A, Kasajima A, Foersch S, Kriegsmann M, Brobeil A, Schmitt M, Wagner D, Poppinga J, Wiese D, Maurer E, Kirschbaum A, Muley T, Winter H, Rinke A, Gress TM, Kremer M, Evert M, Märkl B, Quaas A, Eckstein M, Tschurtschenthaler M, Klöppel G, Denkert C, Bartsch DK, Jesinghaus M. Grass A, et al. Among authors: markl b. Mod Pathol. 2024 Apr;37(4):100442. doi: 10.1016/j.modpat.2024.100442. Epub 2024 Feb 1. Mod Pathol. 2024. PMID: 38309431 Free article.
SARIFA as a new histopathological biomarker is associated with adverse clinicopathological characteristics, tumor-promoting fatty-acid metabolism, and might predict a metastatic pattern in pT3a prostate cancer.
Enke JS, Groß M, Grosser B, Sipos E, Steinestel J, Löhr P, Waidhauser J, Lapa C, Märkl B, Reitsam NG. Enke JS, et al. Among authors: markl b. BMC Cancer. 2024 Jan 12;24(1):65. doi: 10.1186/s12885-023-11771-9. BMC Cancer. 2024. PMID: 38216952 Free PMC article.
Stroma AReactive Invasion Front Areas (SARIFA) improves prognostic risk stratification of perioperative chemotherapy treated oesophagogastric cancer patients from the MAGIC and the ST03 trial.
Grosser B, Emmerson J, Reitsam NG, Cunningham D, Nankivell M, Langley RE, Allum WH, Trepel M, Märkl B, Grabsch HI. Grosser B, et al. Among authors: markl b. Br J Cancer. 2024 Feb;130(3):457-466. doi: 10.1038/s41416-023-02515-4. Epub 2023 Dec 20. Br J Cancer. 2024. PMID: 38123705 Free PMC article.
166 results